DreamJay is a health care startup founded in 2014. The company's slogan "Empowering your nights with science to deliver a happier, healthier sleep experience" encapsulates its mission to revolutionize sleep experiences. DreamJay's innovative approach is the Nightly app, the first of its kind to actively stimulate users during sleep, leading to enhanced sleep efficiency and better overall health. The app's development stems from three years of research in a sleep lab, alongside collaboration with sleep medicine experts, neuropsychologists, and audiovisual researchers. The company recently secured a $2.30M Series A investment on 15 September 2017 from the Joint Polish Investment Fund and Nordic Makers. DreamJay's interdisciplinary team of scientists, designers, and entrepreneurs are dedicated to addressing the universal need for better sleep and dreams. The Nightly app's promise lies in helping people fall asleep easily, reducing bad dreams and nighttime awakenings, and assisting in waking up during the lightest sleep stage. For more information, visit their website at www.nightlyapp.co. This latest investment is a testament to their potential impact in the health and wellness sector and their innovative contributions to the field of sleep science.
No recent news or press coverage available for DreamJay.